Form 4 for CHE CHEMED CORP
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0001209191-22-026964 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-02 | CHE | MCNAMARA KEVIN J | Pres, CEO, Dir | F - Tax | $489.91 | -7,863 | 130.2K | -6% | -$3.85M |
| D | 2022-05-04 | 2022-05-02 | CHE | MCNAMARA KEVIN J | Pres, CEO, Dir | M - OptEx | $306.70 | +10.0K | 138.0K | +8% | +$3.07M |
| D | 2022-05-04 | 2022-05-02 | CHE | MCNAMARA KEVIN J | Pres, CEO, Dir | S - Sale+OE | $486.79 | -3,000 | 128.0K | -2% | -$1.46M |
| D | 2022-05-04 | 2022-05-02 | CHE | MCNAMARA KEVIN J | Pres, CEO, Dir | M - OptEx | $306.70 | -10.0K | 172.3K | -5% | -$3.07M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | capital stock | 2022-05-02 | F | D | 7,863 | $489.91 | 130,185 | D | — | — | |
| 2 | Common | capital stock | 2022-05-02 | M | A | 10,000 | $306.70 | 138,048 | D | — | — | |
| 3 | Common | capital stock | 2022-05-02 | S | D | 3,000 | $486.79 | 128,048 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $479.67 to $496.16. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4. |
| 4 | Derivative | stock option(right to buy with tandem tax withholding) | 2022-05-02 | M | D | 10,000 | $306.70 | 172,327 | D | $306.70 · — to 2032-11-02 | 10,000 capital stock | (F3) Vesting in three equal annual installments commencing 11/2/2019 |